Shares of Cambridge Cognition Holdings Plc (LON:COG – Get Free Report) passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 32.15 and traded as low as GBX 27.10. Cambridge Cognition shares last traded at GBX 27.40, with a volume of 24,906 shares trading hands.
Cambridge Cognition Price Performance
The company has a 50 day moving average price of GBX 31.15 and a 200-day moving average price of GBX 32.15. The company has a market cap of £12.76 million, a price-to-earnings ratio of -7.21 and a beta of 0.72. The company has a quick ratio of 0.96, a current ratio of 0.65 and a debt-to-equity ratio of 92.53.
About Cambridge Cognition
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Read More
- Five stocks we like better than Cambridge Cognition
- Do not delete, read immediately
- The $100 Trillion AI Story No One Is Telling You
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- But this $2 Gold Stock Before May 20, 2026
- First Time Since 2007: All Warnings Active
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
